drugset / Trial / NCT02890953
Efficacy and Safety of Pneumostem® for IVH in Premature Infants (Phase 2a)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The objective of this study is to evaluate the efficacy and safety of a single intraventricular administration of Pneumostem® for treatment of Intraventricular hemorrhage (IVH) in high-risk premature infants by comparing Pneumostem-treated group with a control group.
Timeline
- Start
- 2017-03-28
- Primary completion
- 2025-12
- Completion
- 2025-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PNEUMOSTEM® | Cell therapy | — | Other |
Indications
No indication recorded.